| 2023 | The applicability of prognostic models under rituximab-dose-adjusted EPOCH (R-DA-EPOCH) in primary mediastinal large b-cell lymphoma (PMLBCL) : a comparison with R-CHOP | Vassilakopoulos, Theodoros; Ferhanoglu, B.; Horowitz, Na; Apostolidis, J.; Mellios, Z.; Piperidou, Alexia; Kaynar, L.; Zektser, M.; Giotas, Asterios; Symeonidis, A.; Kalpadakis, C.; Agathocleous, A.; Akay, Om; Sayyed, A.; Atalar, Sc; Katodritou, E.; Leonidopoulou, T.; Papageorgiou, Sg.; Tadmor, T.; Gutwein, O.; Karakatsanis, S.; Ganzel, C.; Karianakis, G.; Isenberg, G. Y.; Gainaru, G.; Vrakidou, E.; Palassopoulou, M.; Ozgur, M.; Siakantaris, Marina; Paydas, S.; Tsirigotis, P.; Tsirogianni, M.; Hatzimichael, E.; Tugular, Tf.; Assimakopoulos, Jv; Ligdi, L.; Liaskas, A.; Lefaki, Maria Aikaterini; Labropoulou, P.; Kopsaftopoulou, A.; Verrou, E,; Kanellias, M.; Zikos, P.; Koumarianou, A.; Gafter- Gvili, A.; Angelopoulou, Mk; Karmiris, T.; Gurion, R. |